Flagship Pioneering Inc.'s Net Worth

$4.81 Billion

Who is Flagship Pioneering Inc.?

Flagship Pioneering Inc. has an estimated net worth of $4.81 Billion. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Moderna, Inc., Kaleido Biosciences, Inc., BG Medicine, Inc., Omega Therapeutics, Inc., Seres Therapeutics, Inc., Foghorn Therapeutics Inc., Codiak BioSciences, Inc., Sigilon Therapeutics, Inc., Evelo Biosciences, Inc., Axcella Health Inc., HELICOS BIOSCIENCES CORP, and ACCELERON PHARMA INC.

SEC CIK

Flagship Pioneering Inc.'s CIK is 0001400240

Past Insider Trading and Trends

2011 was Flagship Pioneering Inc.'s most active year for acquiring shares with 26 total transactions. Flagship Pioneering Inc.'s most active month to acquire stocks was the month of November. 2014 was Flagship Pioneering Inc.'s most active year for disposing of shares, totalling 40 transactions. Flagship Pioneering Inc.'s most active month to dispose stocks was the month of November. 2022 saw Flagship Pioneering Inc. paying a total of $67,525,463.59 for 36,135,502 shares, this is the most they've acquired in one year. In 2023 Flagship Pioneering Inc. cashed out on 12,578,995 shares for a total of $11,901,982.40, their largest year based on trade value.